WOBURN, MA, Jun 15, 2012 (MARKETWIRE via COMTEX) —
Batavia Bioservices, a service provider aiding its customers in the
development of complex biological medicines, has decided to
launch a
US facility in Woburn, Massachusetts. The company is headquarted
in
Leiden, The Netherlands.
Menzo Havenga, President and CEO of Batavia, said: “We have been
growing more
than four hundred percent in the past two years in the
Netherlands and to keep
up with customer demand we have decided to
launch a facility in the Boston area.” Christopher Yallop, COO,
adds: “We have chosen the greater Boston area
due to its importance
as a biotech cluster. Positioning ourselves here allows us to be
close to our customers, which we deem extremely important in
delivering on time and on budget.” Batavia Bioservices provides a
one-stop shop from DNA cloning to Phase I/II clinical manufacturing
for all major classes of biopharmaceuticals, including antibodies,
proteins or vaccines.
“Massachusetts leads the world in life sciences thanks to our growth
strategy of investing in education, innovation and infrastructure,”
said Governor Deval Patrick. “We welcome Batavia Bioservices, and we
look forward to working with
them to create jobs and opportunities in
the Commonwealth.”
“We are excited to welcome Batavia Bioservices to the Massachusetts
Life Sciences community,” said Susan Windham-Bannister, Ph.D.,
President CEO of the Massachusetts Life Sciences Center, the agency
charged with implementing Governor Patrick’s 10-year, $1 billion Life
Sciences Initiative. “Batavia provides important services to the life
sciences industry sectors, and the company’s presence in
Massachusetts will contribute to our economy, as well as
strengthen
our life sciences ecosystem. I am confident that the team at
Batavia
will find all of the resources and partners they need to
thrive in Massachusetts.”
“Batavia Bioservices opening a lab facility in Woburn is a testament
to the critical role Massachusetts plays in the global life sciences
value chain.” said
Ken Brown, Executive Director of the Massachusetts
Office of International Trade
Investment. “I wish the company much
success and look forward to their growing
presence in the
Commonwealth.”
The Woburn facility (+/- 5500 sq feet), located at Cummings
Properties’ TradeCenter 128, contains multiple BSL-2 laboratories
dedicated to specific tasks including Molecular Biology, mammalian
cell line generation, protein production, protein purification or
assay development. The company has already
hired six employees for
the new facility, with plans to hire four more by the
end of this
year. Joan Hilly, Director Cell Sciences, said: “It’s great that we
have been able to quickly staff our facility with experts in their
respective
fields and in fact we have just started executing the
first customer contracts
on site!”
The announcement comes as the state is preparing to host the 2012 BIO
International Convention, being held June 18-21 at the Massachusetts
Convention
Exhibition Center. The Convention provides state and
industry leaders an opportunity to showcase Massachusetts as a great
place to do business for international life sciences companies.
“Batavia’s decision to grow in Massachusetts highlights the strength
of the cluster here in the Commonwealth and the capacity for industry
stakeholders to
work together to get things done,” said Robert
Coughlin, President CEO of MassBio. “We’re thrilled to have such a
cutting-edge, growing, global company
join the Massachusetts
supercluster.”
“The opening of a facility in Woburn by Batavia Bioservices shows
that the Netherlands Life Sciences industry is continuing to spread
its wings,” said Mr.
Rob de Vos, Consul General of the Netherlands in
New York. “In the Netherlands,
Life Sciences clusters located in
various bioscience parks that focus on translational research could
develop due to a combination of high quality (clinical) research,
strong public-private collaborations and a stimulating business
climate. Batavia Bioservices is one of many innovative companies
based
in such a cluster (Bioscience Park in Leiden).”
“It has been a pleasure working with Batavia to meet its specialized
laboratory
needs,” said Dennis Clarke, Cummings Properties’ president
and CEO. “The firm
has a very promising future, and will find good
company here at TradeCenter 128, where several other international
firms have located their U.S. headquarters.”
Batavia Bioservices opens laboratory facility in greater Boston area:
http://hugin.info/148797/R/1620052/517507.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
that: (i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for
the content, accuracy and originality of the information
contained therein.
Source: Batavia Bioservices B.V. via Thomson Reuters ONE
[HUG#1620052]
Contact:
Angus G. McQuilken
MLSC VP for Communications
Email: Email Contact
phone 617-921-7749
SOURCE: Batavia Bioservices B.V.
http://www2.marketwire.com/mw/emailprcntct?id=45E136FCED19C47D
Copyright 2012 Marketwire, Inc., All rights reserved.